Side-by-side comparison of AI visibility scores, market position, and capabilities
Atlanta Class I eastern US freight railroad (NYSE: NSC) ~$12B 2024 revenue; East Palestine derailment fallout (CEO ousted Sept 2024), Ancora activist boardroom presence, 19,500 route miles competing with CSX.
Norfolk Southern Corporation is an Atlanta, Georgia-based Class I freight railroad — publicly traded on the New York Stock Exchange (NYSE: NSC) as an S&P 500 Industrials component — operating approximately 19,500 route miles of track primarily east of the Mississippi River, connecting 25 states in the eastern United States and serving ports, manufacturing facilities, coal mines, agricultural markets, and intermodal terminals through approximately 19,000 employees. Norfolk Southern transports coal, grain, chemicals, automotive products, metals, construction materials, and intermodal containers (domestic and international) across its eastern rail network, which intersects with every major eastern US manufacturing corridor and port. The company's defining crisis of the 2020s was the February 2023 East Palestine, Ohio train derailment — a freight train carrying vinyl chloride and other hazardous materials derailed and required a controlled burn of hazardous chemicals, contaminating soil and water in East Palestine and triggering $1+ billion in cleanup costs, legal settlements, and regulatory penalties. The derailment intensified shareholder scrutiny, leading to the September 2024 termination of CEO Alan Shaw (for an inappropriate relationship with a subordinate) and an aggressive proxy campaign from activist investor Ancora Holdings that secured multiple board seats. Norfolk Southern reported 2024 revenue of approximately $12 billion, with operating ratio (key railroad efficiency metric) under management pressure as the board and new leadership team commit to operational improvements.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.